Swiss National Bank
PLRX icon

Swiss National Bank’s Pliant Therapeutics PLRX Stock Holding History

Swiss National Bank’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-95,700
Closed -$129K – 2388
2025
Q1 		$129K Hold
95,700
– – ﹤0.01% 2397
2024
Q4 		$1.26M Buy
95,700
+1,500
+2% +$20.5K ﹤0.01% 2097
2024
Q3 		$1.06M Buy
94,200
+5,800
+7% +$72.6K ﹤0.01% 2194
2024
Q2 		$950K Hold
88,400
– – ﹤0.01% 2195
2024
Q1 		$1.32M Hold
88,400
– – ﹤0.01% 2080
2023
Q4 		$1.6M Sell
88,400
-2,700
-3% -$41.1K ﹤0.01% 1975
2023
Q3 		$1.58M Sell
91,100
-5,100
-5% -$88.4K ﹤0.01% 1982
2023
Q2 		$1.74M Buy
96,200
+3,700
+4% +$87.6K ﹤0.01% 1979
2023
Q1 		$2.46M Buy
92,500
+4,400
+5% +$125K ﹤0.01% 1710
2022
Q4 		$1.7M Buy
+88,100
New +$1.84M ﹤0.01% 1997
2022
Q2 		– Sell
-29,800
Closed -$209K – 2779
2022
Q1 		$209K Buy
29,800
+2,400
+9% +$24.5K ﹤0.01% 2675
2021
Q4 		$370K Hold
27,400
– – ﹤0.01% 2703
2021
Q3 		$463K Hold
27,400
– – ﹤0.01% 2592
2021
Q2 		$798K Buy
27,400
+3,400
+14% +$106K ﹤0.01% 2547
2021
Q1 		$944K Hold
24,000
– – ﹤0.01% 2364
2020
Q4 		$545K Buy
+24,000
New +$602K ﹤0.01% 2448

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Swiss National Bank's PLRX Position: Q2 2025 in Review

Swiss National Bank sold out of Pliant Therapeutics (PLRX) in Q2 2025, closing a stake of 95,700 shares — an estimated $129K sold.

Swiss National Bank first reported a position in PLRX in Q4 2020 and held it in 16 quarters. The position peaked at $2.46M in Q1 2023. 114 funds tracked by Wall St. Rank hold PLRX as of Q2 2025.

  • Swiss National Bank reported no remaining Pliant Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Swiss National Bank sold 95,700 Pliant Therapeutics shares in Q2 2025, an estimated $129K.
  • Swiss National Bank first reported a position in Pliant Therapeutics in Q4 2020 and held it in 16 quarters.
  • Swiss National Bank's Pliant Therapeutics position peaked at $2.46M in Q1 2023.
  • 114 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2025.

Based on Swiss National Bank's 13F filing for Q2 2025, filed 12 Aug 2025.